"10.1371_journal.pone.0134572","plos one","2015-08-14T00:00:00Z","Daniela Brunner; Patricia Kabitzke; Dansha He; Kimberly Cox; Lucinda Thiede; Taleen Hanania; Emily Sabath; Vadim Alexandrov; Michael Saxe; Elior Peles; Alea Mills; Will Spooren; Anirvan Ghosh; Pamela Feliciano; Marta Benedetti; Alice Luo Clayton; Barbara Biemans","PsychoGenics, Inc., Tarrytown, NY, United States of America; Department of Psychiatry, Columbia University, New York, NY, United States of America; Roche, Basel, Switzerland; Department of Molecular Cell Biology, Weizmann Institute of Science, Rehovot, Israel; Cold Spring Harbor Laboratory, Cold Spring Harbor, NY, United States of America; Simons Foundation Autism Research Initiative, New York, NY, United States of America","Conceived and designed the experiments: DB PK AG WS MS BB MB ALC. Performed the experiments: PK DH KC LT ES. Analyzed the data: DB PK ES TH. Contributed reagents/materials/analysis tools: MS BB DB VA. Wrote the paper: DB PK BB MB ALC PF. Participated in the creation and validation of the animal models under study: EP AM.","DB, PK, DH, KC, LT, TH, ES and VA are employees of PsychoGenics Inc., a Contract Research Organization performing the work. DB holds PsychoGenics shares, has patents related to PsychoGenics highthroughput technologies, board member of IRSF - TSCA, Editor-in-Chief IJCP. TH and VA hold PsychoGenics shares. DB and TH have patents related to partnered drug discovery. MS, WS, AG and BB are employees of Roche, whose company partly funded this study. WS, AG hold Roche shares. There are no patents, products in development or marketed products related to this study to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials.",NA,NA,NA,"2015","08","Daniela Brunner","DB",17,TRUE,8,5,4,6,TRUE,TRUE,FALSE,0,NA,FALSE
